Ovarian Granulosa-Stromal Tumor
1 clinical trials · Condition
◉ Watch Ovarian Granulosa-Stromal Tumor
| Record | Firm | Date |
|---|---|---|
| Nirogacestat in Ovarian Granulosa Cell Tumors (NCT05348356) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2022-08-30 |
Track Ovarian Granulosa-Stromal Tumor automatically
Every clearance here is in the API, with alerts when new ones post.